Angiotensin AT2 receptor stimulation inhibits activation of NADPH oxidase and ameliorates oxidative stress in rotenone model of Parkinson's disease in CATH.a cells

Neurotoxicology and Teratology

Volumn 47, Issue , 2015, Pages 16-24

  Lu, Jie ^b   Wu, Liang ^a   Jiang, Teng ^a   Wang, Yao ^b   Zhao, Hongrui ^a   Gao, Qing ^a   Pan, Yang ^b   Tian, Youyong ^a   Zhang, Yingdong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

CATH.a neurons; CGP42112; Oxidative stress; Parkinson's disease; Rotenone

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; DICHLORODIHYDROFLUORESCEIN DIACETATE; FLUORESCENT DYE; GLUTATHIONE; MESSENGER RNA; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; PHOSPHATE BUFFERED SALINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; ROTENONE; SUPEROXIDE; SUPEROXIDE DISMUTASE; ANGIOTENSIN DERIVATIVE; IMIDAZOLE DERIVATIVE; INSECTICIDE; OLIGOPEPTIDE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERTENSION; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE;

ANALYSIS OF VARIANCE; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANGIOTENSINS; ANIMALS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GLUTATHIONE; IMIDAZOLES; INSECTICIDES; MICE; NADPH OXIDASE; OLIGOPEPTIDES; OXIDATIVE STRESS; PYRIDINES; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA, MESSENGER; ROTENONE; SUPEROXIDE DISMUTASE;

EID: 84912100597     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2014.11.004     Document Type: Article

References (35)

1. Armando I., Jezova M., Bregonzio C., Baiardi G., Saavedra J.M. Angiotensin II AT1 and AT2 receptor types regulate basal and stress-induced adrenomedullary catecholamine production through transcriptional regulation of tyrosine hydroxylase. Ann N Y Acad Sci 2004, 1018:302-309.
2. Bedard K., Lardy B., Krause K.H. NOX family NADPH oxidases: not just in mammals. Biochimie 2007, 89:1107-1112.
3. Carriere C.H., Kang N.H., Niles L.P. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease. Neuroscience 2014, 267:114-121.
4. Caudle W.M., Guillot T.S., Lazo C.R., Miller G.W. Industrial toxicants and Parkinson's disease. Neurotoxicology 2012, 33:178-188.
5. Chai C., Lim K.L. Genetic insights into sporadic Parkinson's disease pathogenesis. Curr Genomics 2013, 14:486-501.
6. Chung Y.C., Kim S.R., Park J.Y., Chung E.S., Park K.W., Won S.Y., et al. Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 2011, 60:963-974.
7. Gaki G.S., Papavassiliou A.G. Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease. Neuromolecular Med 2014, 16:217-230.
8. 2 receptor subtype levels in brain regions from patients with neurodegenerative disorders. Eur J Pharmacol 1996, 297:299-306.
9. Hisahara S., Shimohama S. Toxin-induced and genetic animal models of Parkinson's disease. Park Dis 2010, 2011:951709.
10. Honjo T., Yamaoka-Tojo M., Inoue N. Pleiotropic effects of ARB in vascular metabolism-focusing on atherosclerosis-based cardiovascular disease. Curr Vasc Pharmacol 2011, 9:145-152.
11. Jiang T., Gao L., Lu J., Zhang Y.D. ACE2-Ang-(1-7)-Mas axis in brain: a potential target for prevention and treatment of ischemic stroke. Curr Neuropharmacol 2013, 11:209-217.
12. Kumar V., Gill K.D. Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: a review. Neurotoxicology 2014, 41:154-166.
13. Labandeira-Garcia J.L., Rodriguez-Pallares J., Villar-Cheda B., Rodríguez-Perez A.I., Garrido-Gil P., Guerra M.J. Aging, angiotensin system and dopaminergic degeneration in the substantia nigra. Aging Dis 2011, 2:257-274.
14. Labandeira-Garcia J.L., Rodriguez-Pallares J., Rodríguez-Perez A.I., Garrido-Gil P., Villar-Cheda B., Valenzuela R., et al. Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease. Am J Neurodegener Dis 2012, 1:226-244.
15. Lu J., Jiang T., Wu L., Gao L., Wang Y., Zhou F., et al. The expression of angiotensin-converting enzyme 2-angiotensin-(1-7)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats. Neuropeptides 2013, 47:289-295.
16. Manea S.A., Todirita A., Raicu M., Manea A. C/EBP transcription factors regulate NADPH oxidase in human aortic smooth muscle cells. J Cell Mol Med 2014, 18:1467-1477.
17. Mazzocchi G., Gottardo G., Macchi V., Malendowicz L.K., Nussdorfer G.G. The AT2 receptor-mediated stimulation of adrenal catecholamine release may potentiate the AT1 receptor-mediated aldosterone secretagogue action of angiotensin-II in rats. Endocr Res 1998, 24:17-28.
18. Mertens B., Vanderheyden P., Michotte Y., Sarre S. The role of the central renin-angiotensin system in Parkinson's disease. J Renin Angiotensin Aldosterone Syst 2010, 11:49-56.
19. Miller R.L., James-Kracke M., Sun G.Y., Sun A.Y. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem Res 2009, 34:55-65.
20. Pal R., Monroe T.O., Palmieri M., Sardiello M., Rodney G.G. Rotenone induces neurotoxicity through Rac1-dependent activation of NADPH oxidase in SHSY-5Y cells. FEBS Lett 2014, 588:472-481.
21. Parra-Cid C., García-López J., García E., Ibarra C. An enteric nervous system progenitor cell implant promotes a behavioral and neurochemical improvement in rats with a 6-OHDA-induced lesion. Neurotoxicol Teratol 2014, 43:45-50.
22. Pereira M.G., Souza L.L., Becari C., Duarte D.A., Camacho F.R., Oliveira J.A., et al. Angiotensin II-independent angiotensin-(1-7) formation in rat hippocampus: involvement of thimet oligopeptidase. Hypertension 2013, 62:879-885.
23. Rodriguez-Pallares J., Quiroz C.R., Parga J.A., Guerra M.J., Labandeira-Garcia J.L. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors viaangiotensin type 2 receptors. Eur J Neurosci 2004, 20:1489-1498.
24. Sanders L.H., Greenamyre J.T. Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic Biol Med 2013, 62:111-120.
25. Sandrone S., Catani M. Journal Club. Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease. Neurology 2013, 81:e172-e175.
26. Sapkota K., Kim S., Park S.E., Kim S.J. Detoxified extract of Rhus verniciflua stokes inhibits rotenone-induced apoptosis in human dopaminergic cells, SH-SY5Y. Cell Mol Neurobiol 2011, 31:213-223.
27. Shao B., Bayraktutan U. Hyperglycaemia promotes human brain microvascular endothelial cell apoptosis via induction of protein kinase C-ßI and prooxidant enzyme NADPH oxidase. Redox Biol 2014, 2:694-701.
28. Taetzsch T., Block M.L. Pesticides, microglial NOX2, and Parkinson's disease. J Biochem Mol Toxicol 2013, 27:137-149.
29. Vallet P., Charnay Y., Steger K., Ogier-Denis E., Kovari E., Herrmann F., et al. Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 2005, 132:233-238.
30. Villar-Cheda B., Dominguez-Meijide A., Valenzuela R., Granado N., Moratalla R., Labandeira-Garcia J.L. Aging-related dysregulation of dopamine and angiotensin receptor interaction. Neurobiol Aging 2014, 35:1726-1738.
31. von Bohlen und Halbach O., Albrecht D. The CNS renin-angiotensin system. Cell Tissue Res 2006, 326:599-616.
32. Wakui H., Dejima T., Tamura K., Uneda K., Azuma K., Maeda A., et al. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension. Cardiovasc Res 2013, 100:511-519.
33. Wu J., Lin H., Liu D., Liu J., Wang N., Mei X., et al. The protective effect of telmisartan in Type 2 diabetes rat kidneys is related to the downregulation of thioredoxin-interacting protein. J Endocrinol Invest 2013, 36:453-459.
34. Wu L., Tian Y.Y., Shi J.P., Xie W., Shi J.Q., Lu J., et al. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease. Neurosci Lett 2013, 548:50-55.
35. Wu L., Luo N., Zhao H.R., Gao Q., Lu J., Pan Y., et al. Salubrinal protects against rotenone-induced SH-SY5Y cell death via ATF4-parkin pathway. Brain Res 2014, 1549:52-62.